Understanding how cells transform into specialized types during human development is a central challenge in biology. This ...

Orca Bio announces it met the primary endpoint in its pivotal Phase 3 clinical study for its lead allogeneic T-cell immunotherapy, Orca-T.

Leveragen has announced a strategic partnership with Moonlight Bio, targeting the development of T-cell therapies for ...

Lung cancer is a particularly challenging form of cancer. It often strikes unexpectedly and aggressively with little warning, and it can shapeshift in unpredictable ways to evade treatment.

Fintel reports that on February 10, 2025, D. Boral Capital downgraded their outlook for Annovis Bio (NYSE:ANVS) from Buy to ...

The FDA has granted Fast Track Designation to Adicet Bio’s ADI-001, an allogeneic gamma delta CAR T-cell therapy, for ...

Danés, principal investigator of the Cancer and Stem Cell Biology Lab at the Champalimaud Foundation, in Lisbon, has shown ...

Understanding how cells transform into specialized types during human development is a central challenge in biology. This ...

How can the field of synthetic biology help improve engineered living materials (ELMs)? This is what a recent study published ...

The University of Oulu is at the forefront of developing cutting-edge biosensor technology that could revolutionize the early diagnosis and treatment of diseases.

Researchers created the first bi-paternal mouse by modifying imprinting genes, advancing reproductive science but facing ...

Landmark single-cell dataset of one billion cells will be used to train new AI models to advance understanding of cellular behavior and gene function.